It will be interesting to see the share price reac
Post# of 148288
But, and I probably sound like a broken record, revenue allows us to push our trials. CYDY should be more willing to spend profits as they are non dilutive.
Revenue also attracts talent. Not sure we have ever discussed it, but stock options in a non revenue company are not attractive to many people.